GO:1904178 negative regulation of adipose tissue development: Adipogenesis Suppression, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904178 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of adipose tissue development, a process commonly called negative regulation of adipogenesis.
• Adipose tissue development requires the coordinated differentiation of preadipocytes into mature adipocytes, and its suppression is central to preventing obesity and metabolic disease.
• Key molecular brakes include PPARγ signaling modulators such as ZBTB9, CEBPB, KLF3, and epigenetic regulators like histone methyltransferases.
• Non-coding RNAs and extracellular matrix proteins such as circGLIS3 and fibrillin-1 can inhibit adipogenesis and adipose tissue expansion.
• Dysregulation of negative regulation of adipose tissue development contributes to obesity, insulin resistance, lipodystrophy, and skeletal muscle fat infiltration.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect causal genes in this process.
Description
Adipose tissue development, or adipogenesis, is the process by which undifferentiated mesenchymal precursors commit to the adipocyte lineage and mature into lipid-laden cells. The Gene Ontology term GO:1904178, negative regulation of adipose tissue development, captures any process that stops, prevents, or reduces the frequency, rate, or extent of this developmental program. Because excessive adipose tissue expansion underlies obesity and its metabolic complications, understanding the molecular brakes on adipogenesis is a major research priority. This article synthesizes authoritative QuickGO annotation and published literature to describe the mechanisms, key genes, disease links, and experimental strategies for studying GO:1904178.
negative regulation of adipose tissue development At A Glance
| GO ID | GO:1904178 |
|---|---|
| GO term | negative regulation of adipose tissue development |
| Ontology | biological_process |
| Synonym | negative regulation of adipogenesis; inhibition of adipogenesis; downregulation of adipose tissue development |
| Major function | Suppression of adipocyte differentiation and adipose tissue expansion |
| Definition | Any process that stops, prevents or reduces the frequency, rate or extent of adipose tissue development. |
| Related processes | Adipogenesis, lipid metabolism, energy homeostasis, insulin sensitivity |
| Key regulators | PPARγ, CEBPB, KLF3, ZBTB9, histone methyltransferases, circGLIS3, fibrillin-1 |
| Disease relevance | Obesity, insulin resistance, lipodystrophy, skeletal muscle fat infiltration |
What Is GO:1904178?
GO:1904178 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of adipose tissue development. In practice, it encompasses molecular events that inhibit the commitment of precursor cells to the adipocyte lineage, suppress the differentiation of preadipocytes into mature adipocytes, or restrict the growth and expansion of adipose tissue depots. Synonyms include negative regulation of adipogenesis, inhibition of adipogenesis, and downregulation of adipose tissue development.
Why Is negative regulation of adipose tissue development Important in Cell Biology?
Negative regulation of adipose tissue development is critical for maintaining metabolic health. Excessive adipogenesis leads to obesity, which is a major risk factor for type 2 diabetes, cardiovascular disease, and certain cancers. Conversely, insufficient adipose tissue can cause lipodystrophy and ectopic lipid deposition in muscle and liver. Understanding the endogenous inhibitors of adipogenesis provides therapeutic targets for preventing or treating obesity and related metabolic disorders.
• Prevents excessive adipose tissue expansion and obesity.
• Maintains insulin sensitivity and systemic glucose homeostasis.
• Protects against ectopic fat deposition in skeletal muscle and liver.
• Regulates energy balance and thermogenesis.
• Influences adipokine secretion and chronic inflammation.
• Provides targets for anti-obesity therapeutics.
• Modulates adipose tissue macrophage polarization and immune-metabolic crosstalk.
• Controls developmental timing of adipose depots.
• Dysregulation is linked to lipodystrophy and metabolic syndrome.
• Serves as a model for studying epigenetic and non-coding RNA regulation of differentiation.
What Happens During negative regulation of adipose tissue development?
Inhibition of adipogenic commitment
In simple terms: Stem cells are stopped from becoming fat cells.
Mesenchymal stem cells and preadipocytes can be prevented from committing to the adipocyte lineage by factors that suppress early transcriptional programs. For example, circGLIS3 inhibits intramuscular adipogenesis and alleviates skeletal muscle fat infiltration, acting as a brake on commitment. Similarly, fibrillin-1 regulates white adipose tissue development and homeostasis, influencing the initial stages of depot formation.
Suppression of pro-adipogenic transcription factors
In simple terms: Master switches for fat cell formation are turned down.
The transcription factor PPARγ is the master regulator of adipogenesis, and its activity is tightly controlled. ZBTB9 regulates PPARγ signaling in a cell-state-dependent manner, and its modulation can suppress adipocyte differentiation. CEBPB is another key pro-adipogenic factor; Garcinia cambogia attenuates adipogenesis by affecting CEBPB and promoting selective autophagic degradation of KLF3 through RPS6KA1 and STAT3 suppression.
Epigenetic silencing of adipogenic genes
In simple terms: Chemical tags on DNA and histones lock away fat-forming genes.
Histone methyltransferases regulate adipogenesis by depositing or removing methyl marks on histones, thereby altering chromatin accessibility at pro-adipogenic loci. This epigenetic layer provides a reversible mechanism for negative regulation of adipose tissue development.
Autophagic degradation of adipogenic proteins
In simple terms: Cellular recycling machines destroy proteins that promote fat cell formation.
Selective autophagy can target pro-adipogenic proteins for degradation. For instance, SQSTM1/p62-mediated selective autophagic degradation of KLF3 contributes to the suppression of adipogenesis. This illustrates how proteostasis pathways intersect with negative regulation of adipose tissue development.
Extracellular matrix and niche signals
In simple terms: The scaffold around cells sends stop signals for fat tissue growth.
Fibrillin-1, a major extracellular matrix component, regulates white adipose tissue development, homeostasis, and function. Matrix remodeling and integrin signaling can therefore restrain adipose tissue expansion, representing an additional layer of negative regulation.
Key Genes Involved in GO:1904178 negative regulation of adipose tissue development
The following genes and proteins have been experimentally implicated in the negative regulation of adipose tissue development, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PPARγ | Master regulator of adipogenesis; its inhibition suppresses fat cell formation | Central target for anti-adipogenic interventions |
| CEBPB | Pro-adipogenic transcription factor; its suppression inhibits adipogenesis | Target of natural compounds like Garcinia cambogia |
| KLF3 | Adipogenic transcription factor; its autophagic degradation blocks adipogenesis | Links autophagy to adipogenesis suppression |
| ZBTB9 | Modulates PPARγ signaling in a cell-state-dependent manner | Potential therapeutic target for obesity |
| circGLIS3 | Circular RNA that inhibits intramuscular adipogenesis | Biomarker or therapeutic for skeletal muscle fat infiltration |
| FBN1 (Fibrillin-1) | Extracellular matrix protein regulating white adipose tissue development | Links matrix biology to adipose homeostasis |
| Histone methyltransferases | Epigenetic regulators of adipogenic gene expression | Targets for epigenetic therapy in obesity |
| SQSTM1/p62 | Selective autophagy receptor mediating KLF3 degradation | Connects proteostasis to adipogenesis inhibition |
| RPS6KA1 | Kinase involved in signaling that suppresses adipogenesis | Potential drug target |
| STAT3 | Transcription factor whose suppression promotes KLF3 degradation | Modulates inflammatory and metabolic signaling |
| Adipose tissue macrophages | Immune cells that can influence adipogenesis and inflammation | Targets for obesity and metabolic diseases |
| Wnt/β-catenin components | Signaling pathway that inhibits adipogenesis | Well-established negative regulators |
| TGF-β/Smad signaling | Inhibits adipocyte differentiation | Context-dependent regulator |
| Notch signaling | Suppresses adipogenesis in some contexts | Developmental regulator |
| Pref-1 (DLK1) | Inhibits adipocyte differentiation | Marker of preadipocytes |
| GATA2/3 | Transcription factors that inhibit adipogenesis | Early inhibitors |
| KLF2 | Negative regulator of adipogenesis | Anti-adipogenic transcription factor |
How Is negative regulation of adipose tissue development Regulated?
Negative regulation of adipose tissue development is controlled by a network of signaling pathways and epigenetic modifiers. The Wnt/β-catenin, TGF-β/Smad, and Notch pathways are classical inhibitors of adipogenesis. Epigenetic enzymes such as histone methyltransferases modulate chromatin states at pro-adipogenic loci. Non-coding RNAs, including circular RNAs like circGLIS3, can sequester microRNAs or interact with proteins to suppress adipogenesis. Autophagic pathways, such as SQSTM1/p62-mediated degradation of KLF3, provide post-translational control. Inflammatory signals from adipose tissue macrophages can also influence adipocyte differentiation and function.
negative regulation of adipose tissue development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PPARγ | Obesity, insulin resistance | Knockout or point-mutation in preadipocytes |
| CEBPB | Obesity, adipogenesis | Overexpression or knockout in 3T3-L1 cells |
| KLF3 | Adipogenesis, autophagy | Knockout with autophagy reporter |
| circGLIS3 | Skeletal muscle fat infiltration | Overexpression in intramuscular preadipocytes |
| FBN1 | White adipose tissue homeostasis | Knockout mouse models |
Obesity and metabolic syndrome
Impaired negative regulation of adipose tissue development leads to excessive adipogenesis and obesity, which is a major risk factor for type 2 diabetes, dyslipidemia, and cardiovascular disease. Enhancing the molecular brakes on adipogenesis is a therapeutic strategy for obesity.
Skeletal muscle fat infiltration
Ectopic fat accumulation in skeletal muscle is associated with insulin resistance and muscle dysfunction. circGLIS3 inhibits intramuscular adipogenesis and alleviates skeletal muscle fat infiltration, highlighting the importance of negative regulation in this context.
Lipodystrophy and ectopic lipid deposition
Insufficient adipose tissue development can cause lipodystrophy, leading to ectopic lipid storage in liver and muscle, insulin resistance, and metabolic complications. Proper negative regulation must be balanced to maintain healthy adipose tissue function.
Adipose tissue inflammation
Adipose tissue macrophages contribute to chronic low-grade inflammation in obesity. Modulating their function may indirectly affect adipogenesis and represent a target for metabolic diseases.
From negative regulation of adipose tissue development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X inhibit adipogenesis? | CRISPR knockout in preadipocyte cell line (e.g., 3T3-L1) |
| Does a point mutation in gene Y alter its anti-adipogenic function? | CRISPR point mutation knock-in |
| Does overexpression of gene Z suppress fat accumulation? | CRISPR activation or lentiviral overexpression |
| Does a tagged version of protein W localize to specific compartments during adipogenesis? | CRISPR knock-in of fluorescent tag |
| Which genes are essential for negative regulation of adipose tissue development? | Genome-wide CRISPR library screening |
| Does a candidate gene affect adipose tissue in vivo? | Adipose-specific knockout mouse |
How to Study the negative regulation of adipose tissue development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify anti-adipogenic pathways |
| ChIP-seq | Histone modifications and TF binding | Map epigenetic silencing |
| ATAC-seq | Chromatin accessibility | Assess promoter opening during adipogenesis |
| Proteomics | Protein abundance and modifications | Detect autophagic degradation of KLF3 |
| Oil Red O staining | Lipid accumulation | Quantify adipocyte differentiation |
| CRISPR screen | Essential genes for a phenotype | Discover negative regulators |
| Western blot | Protein expression and signaling | Validate PPARγ and CEBPB levels |
Transcriptomic profiling (RNA-seq)
RNA sequencing can identify global changes in gene expression during negative regulation of adipose tissue development, revealing pathways and non-coding RNAs such as circGLIS3.
Epigenomic analysis (ChIP-seq, ATAC-seq)
These methods map histone modifications and chromatin accessibility to understand how epigenetic regulators like histone methyltransferases suppress adipogenic genes.
Proteomic and autophagy flux assays
Proteomics and autophagy flux assays can detect selective degradation of pro-adipogenic proteins such as KLF3 via SQSTM1/p62.
Imaging and lipid staining
Fluorescence microscopy with lipid dyes (e.g., Oil Red O, Bodipy) quantifies adipocyte differentiation and lipid accumulation in vitro and in vivo.
How CRISPR Can Be Used to Study GO:1904178 negative regulation of adipose tissue development
Knockout
CRISPR knockout of candidate negative regulators (e.g., ZBTB9, KLF3) in preadipocyte cell lines can test whether they are required to suppress adipogenesis. Knockout of PPARγ abolishes adipogenesis, confirming its central role.
Point Mutation
Introducing precise point mutations in genes such as PPARγ or CEBPB can dissect phosphorylation sites or DNA-binding residues that mediate negative regulation of adipose tissue development.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci like ZBTB9 allows live-cell imaging of protein localization during adipogenesis. Knock-in of loxP sites enables conditional alleles in mice.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of circGLIS3 or other inhibitors can suppress adipogenesis and reduce fat accumulation in vitro and in vivo.
How EDITGENE Supports negative regulation of adipose tissue development Research
Researchers studying negative regulation of adipose tissue development-related genes often need to determine whether a candidate gene is causally involved in suppressing adipogenesis or is merely correlated with the phenotype. EDITGENE provides a comprehensive suite of CRISPR services to establish causality and dissect molecular mechanisms.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of adipose tissue development research.
Frequently Asked Questions About negative regulation of adipose tissue development
What is GO:1904178?
GO:1904178 is the Gene Ontology term for negative regulation of adipose tissue development, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of adipose tissue development.
What genes are involved in negative regulation of adipose tissue development?
Key genes include PPARγ, CEBPB, KLF3, ZBTB9, circGLIS3, FBN1, and histone methyltransferases, among others.
How does negative regulation of adipogenesis prevent obesity?
By inhibiting the differentiation of preadipocytes into mature adipocytes, it reduces adipose tissue expansion and helps maintain metabolic health.
What is the role of PPARγ in negative regulation of adipose tissue development?
PPARγ is the master regulator of adipogenesis; its inhibition or modulation suppresses fat cell formation.
How do histone methyltransferases regulate adipogenesis?
They deposit or remove methyl marks on histones, altering chromatin accessibility at pro-adipogenic genes and thereby suppressing differentiation.
What is the link between circGLIS3 and intramuscular adipogenesis?
circGLIS3 inhibits intramuscular adipogenesis and alleviates skeletal muscle fat infiltration.
How can CRISPR be used to study negative regulation of adipose tissue development?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in adipogenesis.
What diseases are associated with dysregulated negative regulation of adipose tissue development?
Obesity, insulin resistance, lipodystrophy, and skeletal muscle fat infiltration are linked to dysregulation of this process.
What is the role of autophagy in negative regulation of adipogenesis?
Selective autophagy can degrade pro-adipogenic proteins such as KLF3 via SQSTM1/p62, thereby suppressing adipogenesis.
How does fibrillin-1 regulate white adipose tissue development?
Fibrillin-1 is an extracellular matrix protein that regulates white adipose tissue development, homeostasis, and function.
Conclusion
GO:1904178, negative regulation of adipose tissue development, is a critical biological process that restrains adipogenesis and adipose tissue expansion. Its molecular players, including PPARγ, CEBPB, KLF3, ZBTB9, circGLIS3, and epigenetic regulators, offer promising targets for combating obesity and metabolic diseases. CRISPR-based models are indispensable for establishing causality and translating these findings into therapies. EDITGENE provides end-to-end CRISPR services to accelerate research in this field.
References
- 1. Ghaben AL et al.. 2019. Adipogenesis and metabolic health.. Nat Rev Mol Cell Biol 20(4):242-258 PMID: 30610207
- 2. Li X et al.. 2023. Adipose tissue macrophages as potential targets for obesity and metabolic diseases.. Front Immunol 14:1153915 PMID: 37153549
- 3. Yu S et al.. 2025. CircGLIS3 Inhibits Intramuscular Adipogenesis and Alleviates Skeletal Muscle Fat Infiltration.. J Cachexia Sarcopenia Muscle 16(4):e70009 PMID: 40735833
- 4. Han JH et al.. 2022. Garcinia cambogia attenuates adipogenesis by affecting CEBPB and SQSTM1/p62-mediated selective autophagic degradation of KLF3 through RPS6KA1 and STAT3 suppression.. Autophagy 18(3):518-539 PMID: 34101546
- 5. Haider N et al.. 2019. Harnessing adipogenesis to prevent obesity.. Adipocyte 8(1):98-104 PMID: 30848691
- 6. Zhao Y et al.. 2024. Regulation of adipogenesis by histone methyltransferases.. Differentiation 136:100746 PMID: 38241884
- 7. Muthu ML et al.. 2022. Fibrillin-1 regulates white adipose tissue development, homeostasis, and function.. Matrix Biol 110:106-128 PMID: 35533973
- 8. Xu X et al.. 2024. Cell-state-dependent regulation of PPARγ signaling by the transcription factor ZBTB9 in adipocytes.. J Biol Chem 300(12):107985 PMID: 39542250
